Novel Insights into PML-Dependent Oncosuppression

Trends Cell Biol. 2016 Dec;26(12):889-890. doi: 10.1016/j.tcb.2016.09.001. Epub 2016 Sep 20.

Abstract

At odds with its nuclear counterpart, extranuclear promyelocytic leukemia constitutively inhibits autophagy, hence limiting cancer progression. These data raise the interesting possibility that some tumor suppressors have become specialized to operate at multiple subcellular compartments for counteracting different aspects of the oncogenic process.

Keywords: MAMs; autophagy; beclin 1; chloroquine; p53; regulated cell death.

Publication types

  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Animals
  • Genes, Tumor Suppressor*
  • Humans
  • Mice
  • Models, Biological
  • Promyelocytic Leukemia Protein / metabolism*
  • Tumor Suppressor Protein p53 / metabolism

Substances

  • Promyelocytic Leukemia Protein
  • Tumor Suppressor Protein p53